MetaCap

Acrivon Therapeutics Insider Trades

NASDAQ: ACRVHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.91+0.04 (+2.14%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
10 · $40.39K
Shares bought / sold
0 / 19.05K
Net activity
Net selling $40,392

Acrivon Therapeutics insider activity

Over the last 12 months, Acrivon Therapeutics insiders reported 35 transactions on SEC Form 4: 0 open-market purchases and 10 sales. Insiders bought $0 and sold $40,392 worth of stock, for net insider selling of $40,392. The largest seller was Blume-Jensen Peter & Masson Kristina, with $34,412 in reported sales.

The most recent filing shows Miller Mary (Chief Legal Officer) selling 294 shares at $1.99 on Oct 5, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ACRV's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

ACRV insider transactions

Acrivon Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Oct 5, 2026Miller MaryChief Legal OfficerSale294$585.06Form 4
Aug 31, 2026Levin MichaelaChief Business OfficerAward30,000—Form 4
Aug 25, 2026Blume-Jensen Peter & Masson KristinaPresident and CEOSale14,036$30.97KForm 4
Aug 18, 2026Blume-Jensen Peter & Masson KristinaPresident and CEOSale484$972.84Form 4
Aug 18, 2026Blume-Jensen Peter & Masson KristinaPresident and CEOSale1,229$2.47KForm 4
Aug 18, 2026Devroe EricChief Operating OfficerSale604$1.21KForm 4
Aug 18, 2026Gamelin ErickChief Development OfficerSale400$804Form 4
Aug 18, 2026Miller MaryChief Legal OfficerSale185$371.85Form 4
Aug 18, 2026Peterson KatharineChief Accounting OfficerSale101$203.01Form 4
Aug 4, 2026Levy Adam D.Chief Financial OfficerSale1,142$1.79KForm 4
Jul 21, 2026Miller MaryChief Legal OfficerSale573$1.01KForm 4
May 21, 2026Blume-Jensen Peter & Masson KristinaPresident and CEOTax withholding13,729$24.57KForm 4
May 18, 2026Devroe EricChief Operating OfficerAward72,981—Form 4
May 18, 2026Gamelin ErickChief Development OfficerAward38,584—Form 4
May 18, 2026Levy Adam D.Chief Financial OfficerAward46,167—Form 4
May 18, 2026Blume-Jensen Peter & Masson KristinaPresident and CEOAward72,706—Form 4
May 18, 2026Blume-Jensen Peter & Masson KristinaPresident and CEOAward180,095—Form 4
May 18, 2026Miller MaryChief Legal OfficerAward49,830—Form 4
May 18, 2026Mirza Mansoor RazaChief Medical OfficerAward38,817—Form 4
May 18, 2026Peterson KatharineChief Accounting OfficerAward14,227—Form 4
May 18, 2026DiRocco DerekDirectorAward9,366—Form 4
May 18, 2026BAUM CHARLES MDirectorAward9,366—Form 4
May 18, 2026Magovcevic-Liebisch IvanaDirectorAward9,366—Form 4
May 18, 2026Palani SanthoshDirectorAward9,366—Form 4
May 18, 2026TOMSICEK MICHAEL JOHNDirectorAward9,366—Form 4
May 18, 2026Shacham SharonDirectorAward9,366—Form 4
May 18, 2026RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund II, L.P. & Kolchinsky Peter & Shah Rajeev M.DirectorAward9,366—Form 4
May 14, 2026Blume-Jensen Peter & Masson KristinaPresident and CEOTax withholding490$940.80Form 4
May 14, 2026Blume-Jensen Peter & Masson KristinaPresident and CEOTax withholding1,253$2.41KForm 4
May 14, 2026Devroe EricChief Operating OfficerTax withholding613$1.18KForm 4
May 14, 2026Gamelin ErickChief Development OfficerTax withholding404$775.68Form 4
May 14, 2026Miller MaryChief Legal OfficerTax withholding184$353.28Form 4
May 14, 2026Peterson KatharineChief Accounting OfficerTax withholding99$190.08Form 4
Apr 22, 2026RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund II, L.P. & Kolchinsky Peter & Shah Rajeev M.DirectorAward3,888,888$7.00MForm 4
Apr 17, 2026Miller MaryChief Legal OfficerTax withholding558$993.24Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related